Skip to main content
All lobbying filings

FAEGRE DRINKER BIDDLE & REATH LLP

Lobbying for EVERYLIFE FOUNDATION FOR RARE DISEASES · Advocacy organization focused on issues of importance to the rare disease community

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Jul 20, 2026

Official filing document

 Lobbying activity 2
Budget/Appropriations

FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.

Health Issues

Policies pertaining to rare disease therapy development; upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem